Literature DB >> 1647539

Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice.

H C Jackson1, D J Nutt.   

Abstract

The effects of the selective opioid antagonists cyprodime (mu; 1, 3, 10, 30 mg/kg IP), norbinaltorphimine (kappa; 3, 10, 30 mg/kg IP) and naltrindole (delta; 0.3, 1, 3, 10 mg/kg IP) on electroshock seizure threshold in mice were compared with those of the universal opioid antagonist naloxone (0.3, 1, 10 mg/kg IP). Seizure threshold was increased by mu-receptor blocking doses of both cyprodime and naloxone, unaltered by norbinaltorphimine and decreased (in a dose-related manner) by all doses of naltrindole. The effects of naltrindole were similar to those of the established pro-convulsant agent bicuculline (1 mg/kg IP); however, naloxone and cyprodime produced relatively small increases in seizure threshold when compared with phenytoin (doses up to 30 mg/kg IP). The differential effects of mu-, kappa- and delta-receptor antagonists obtained in this study suggest that electroshock seizure threshold in mice may be controlled, at least in part, by a balance between endogenous opioids acting either pro-convulsantly through mu-receptors or anti-convulsantly via delta-receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647539     DOI: 10.1007/bf02244293

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Exploring delta-receptor function using the selective opioid antagonist naltrindole.

Authors:  H C Jackson; T L Ripley; D J Nutt
Journal:  Neuropharmacology       Date:  1989-12       Impact factor: 5.250

2.  U50,488, a highly selective kappa opioid: anticonvulsant profile in rats.

Authors:  F C Tortella; L Robles; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

3.  Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model.

Authors:  F C Tortella; E Echevarria; A W Lipkowski; A E Takemori; P S Portoghese; J W Holaday
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

4.  PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats.

Authors:  F C Tortella; L Robles; E Echevarria; J C Hunter; J Hughes
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.

Authors:  P S Portoghese; A W Lipkowski; A E Takemori
Journal:  Life Sci       Date:  1987-03-30       Impact factor: 5.037

6.  Naloxone-induced epileptogenesis has brain-site specificity in rats.

Authors:  L D Calder; E W Snyder; R E Dustman
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

7.  Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid.

Authors:  F C Tortella; J B Long
Journal:  Brain Res       Date:  1988-07-19       Impact factor: 3.252

8.  Norbinaltorphimine: antagonist profile at kappa opioid receptors.

Authors:  P J Birch; A G Hayes; M J Sheehan; M B Tyers
Journal:  Eur J Pharmacol       Date:  1987-12-15       Impact factor: 4.432

9.  Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.

Authors:  H H Frey
Journal:  Pharmacol Toxicol       Date:  1988-03

10.  Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

Authors:  A E Takemori; B Y Ho; J S Naeseth; P S Portoghese
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

View more
  4 in total

1.  Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice.

Authors:  H C Jackson; S L Dickinson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Investigation of the involvement of opioid receptors in the action of anticonvulsants.

Authors:  H C Jackson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Investigation of the opioid system in absence seizures with positron emission tomography.

Authors:  P A Bartenstein; J S Duncan; M C Prevett; V J Cunningham; D R Fish; A K Jones; S K Luthra; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

4.  Antinociceptive Activity of the Skin Secretion of Phyllomedusa rohdei (Amphibia, Anura).

Authors:  Elena Lucia Anna Malpezzi-Marinho; Cristiane Isabel Silva Zanoni; Graziella Rigueira Molska; Camila Paraventi; Raphael Wuo-Silva; Laís Fernanda Berro; Carlos Amilcar Parada; Eduardo Koji Tamura; Eduardo Ary Villela Marinho
Journal:  Toxins (Basel)       Date:  2020-09-11       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.